Bo D. K.
- Country
- The Netherlands
- Department
- Rheumatology
Research Overview
Data & Insights
Has run more than one trial at 0 of 3 partner sites.
Specializations
Rheumatology & Inflammatory Disorders
The investigator concentrates on inflammatory musculoskeletal conditions, emphasizing disease‑modifying strategies for chronic joint pain and systemic inflammation.
- Polymyalgia rheumatica
- Hand osteoarthritis
- Persistent joint pain
- Glucocorticoid‑sparing therapies
Research integrates patient‑reported outcomes to refine therapeutic thresholds.
Cardiovascular & Thrombotic Disease
Focus lies on atherosclerotic cardiovascular disease and related thrombo‑embolic disorders, targeting risk reduction and heart‑failure management.
- ASCVD risk modulation
- Atrial fibrillation stroke prevention
- Heart failure with reduced ejection fraction
- Secondary prevention after myocardial infarction
Studies often assess composite cardiovascular endpoints.
Pulmonary & Respiratory Medicine
Therapeutic interest includes chronic obstructive pulmonary disease, bronchiectasis, and acute respiratory distress syndrome, aiming to improve lung function and reduce exacerbations.
- COPD exacerbation reduction
- Bronchiectasis with Pseudomonas colonisation
- Management of ARDS secondary to infection
- Idiopathic pulmonary fibrosis
Interventions explore both inhaled agents and systemic anti‑inflammatory approaches.
Oncology & Hematologic Malignancies
The investigator participates in trials for lymphoid malignancies and solid tumours, concentrating on targeted and immunotherapeutic regimens.
- Diffuse large B‑cell lymphoma
- Follicular lymphoma
- Advanced non‑small cell lung cancer
- Hormone‑receptor positive breast cancer
Outcomes include progression‑free survival and quality‑of‑life metrics.
Renal & Metabolic Disorders
Research addresses chronic kidney disease, especially in diabetic populations, and severe hypertriglyceridaemia, seeking to mitigate renal decline and cardiovascular risk.
- CKD progression in type 2 diabetes
- Hypertriglyceridaemia management
- Kidney failure composite outcomes
- Lipid‑lowering therapy in high‑risk patients
Biomarker monitoring supports individualized treatment decisions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.